6 Best Peptides for Polycystic Ovary Syndrome (PCOS)
People pursuing peptide support for Polycystic Ovary Syndrome (PCOS) are working with a genuinely complex condition, one driven by insulin resistance, androgen excess, disrupted hormone signaling, and follicular arrest, often in combination. The compounds people actually reach for span a wide range: from FDA-approved GLP-1 receptor agonists used off-label through telemedicine to research-stage neuroendocrine modulators that target hormonal root causes more directly. This guide walks through six compounds that consistently appear in the research, in clinical practice, and across community discussions of PCOS management. They are ordered by how prominently each appears in the published literature and in real-world use, not ranked as a recommendation of one over another. The right approach depends on your specific PCOS subtype, your health history, and what you build with your care team or through the MyPeptidePal app.
